FDA Inspection 865516 — Nuvasive PR, Inc.

Nuvasive PR, Inc. — FEI 3009144915

The FDA completed an inspection of Nuvasive PR, Inc. on February 11, 2014 in Guaynabo, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 11, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Guaynabo, PR (United States)

Citations

IDCFRDescription
1243721 CFR 1271.270(a)Records incomplete